Thromb Haemost 1992; 68(04): 436-441
DOI: 10.1055/s-0038-1646293
Original Article
Schattauer GmbH Stuttgart

The Hemodynamic and Fibrinolytic Response to Low Dose Epinephrine and Phenylephrine Infusions During Total Hip Replacement Under Epidural Anesthesia

Nigel E Sharrock
The Department of Anesthesiology, The Hospital for Special Surgery, New York, USA
,
George Go
The Department of Anesthesiology, The Hospital for Special Surgery, New York, USA
,
Robert Mineo
The Department of Anesthesiology, The Hospital for Special Surgery, New York, USA
,
Peter C Harpel
1   The Division of Hematology, Mount Sinai School of Medicine, New York, USA
› Author Affiliations
Further Information

Publication History

Received 27 January 1992

Accepted after revision 05 May 1992

Publication Date:
04 July 2018 (online)

Summary

Lower rates of deep vein thrombosis have been noted following total hip replacement under epidural anesthesia in patients receiving exogenous epinephrine throughout surgery. To determine whether this is due to enhanced fibrinolysis or to circulatory effects of epinephrine, 30 patients scheduled for primary total hip replacement under epidural anesthesia were randomly assigned to receive intravenous infusions of either low dose epinephrine or phenylephrine intraoperatively. All patients received lumbar epidural anesthesia with induced hypotension and were monitored with radial artery and pulmonary artery catheters.

Patients receiving low dose epinephrine infusion had maintenance of heart rate and cardiac index whereas both heart rate and cardiac index declined significantly throughout surgery in patients receiving phenylephrine (p = 0.0001 and p = 0.0001, respectively). Tissue plasminogen activator (t-PA) activity increased significantly during surgery (p <0.0005) and declined below baseline postoperatively (p <0.005) in both groups. Low dose epinephrine was not associated with any additional augmentation of fibrinolytic activity perioperatively. There were no significant differences in changes in D-Dimer, t-PA antigen, α2-plasmin inhibitor-plasmin complexes or thrombin-antithrombin III complexes perioperatively between groups receiving low dose epinephrine or phenylephrine. The reduction in deep vein thrombosis rate with low dose epinephrine is more likely mediated by a circulatory mechanism than by augmentation of fibrinolysis.

 
  • REFERENCES

  • 1 Sharrock NE, Ranawat CS, Urquhart B. Factors influencing deep vein thrombosis following total hip arthroplasty under hypotensive anesthesia. Reg Anesth 1991; 15: 33
  • 2 Modig J. Influence of regional anesthesia, local anesthetics, and sympathicomimetics on the pathophysiology of deep vein thrombosis. Acta Chir Scand Suppl 1988; 550: 119-127
  • 3 Stratton JR, Pfeifer MA, Ritchie JL, Halter JB. Hemodynamic effects of epinephrine: concentration-effect study in humans. J Appl Physiol 1985; 58: 1199-1206
  • 4 Sung BH, Robinson C, Thadani U, Lee R, Wilson MF. Effects of 1-epinephrine on hemodynamics and cardiac function in coronary disease: Dose response studies. Clin Pharmacol Ther 1988; 43: 308-316
  • 5 Fellows IW, Bennett T, MacDonald IA. The effect of adrenaline upon cardiovascular and metabolic functions in man. Clin Sci 1985; 69: 215-222
  • 6 Bevan JA, Bevan RD, Duckies SP. Adrenergic regulation of vascular smooth muscle. In: Handbook of Physiology.. Geiger SR. (ed) Am Physiol Soc, Bethesda, MD: 1980. pp 515-566
  • 7 Ogawa S, Gerlach H, Esposito C, Pasagian-Macaulay A, Brett J, Stern D. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. J Clin Invest 1990; 85: 1090-1098
  • 8 Larsson PT, Wiman B, Olsson G, Angelin B, Hjemdahl P. Influence of metroprolol treatment on sympatho-adrenal activation of fibrinolysis. Thromb Haemostas 1990; 63: 482-487
  • 9 Rosing DR, Redweed D, Brakman P, Astrup T, Epstein SE. The fibrinolytic response of man to vasoactive drugs measured in arterial blood. Thromb Res 1978; 13: 419-428
  • 10 Sharrock NE, Mineo R, Urquhart B. Hemodynamic response to low-dose epinephrine infusion during hypotensive epidural anesthesia for total hip replacement. Reg Anesth 1990; 15: 295-299
  • 11 Ratnoff OD. Some Therapeutic Agents Influencing Hemostasis. In: Hemostasis and Thrombosis – Basic Principles and Clinical Practice.. Colman RW, Hirsh J, Marden VJ, Salzman EW. (eds) JB Lippincott Co, Philadelphia, PA: 1987. pp 1026-1047
  • 12 Levin RI, Harpel PC, Weil D, Chang T-S, Rifkin DB. Aspirin inhibits vascular plasminogen activator activity in vivo. J Clin Invest 1984; 74: 571-580
  • 13 Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin administration to normal subjects. N Engl J Med 1989; 320: 1165-1172
  • 14 Davis FM, McDermott E, Hickton C, Wells E, Heaton DC, Laurenson VG, Gillespie WJ, Foate J. Influence of spinal and general anaesthesia on haemostasis during total hip arthroplasty. Br J Anaesth 1987; 59: 561-571
  • 15 Modig J, Borg T, Bagge L, Saldeen T. Role of extradural and of general anaesthesia in fibrinolysis and coagulant after total hip replacement. Br J Anaesth 1983; 55: 625-629
  • 16 Dooijewaard G, de Boer A, Turion PNC, Cohen AF, Breimer DD, Kluft C. Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasma. Thromb Haemostas 1991; 65: 82-86
  • 17 Hansen J-B, Wilsgard L, Olsen JO, Osterus B. Formation and persistence of procoagulant and fibrinolytic activities in circulation after strenuous physical exercise. Thromb Haemostas 1990; 64: 385-389
  • 18 Urano T, Cho M, Takahashi S, Sumiyoshi K, Nakamura M, Mori T, Takada Y, Takada A. Changes of parameters in fibrinolytic system caused by mental stress. Thromb Res 1990; 60: 501-507
  • 19 Chandler WL, Mornin D, Whitten RO, Angleton P, Farin FM, Fritsche TR, Veith RC, Stratton JR. Insulin, cortisol and catecholamines do not regulate circadian variations in fibrinolytic activity. Thromb Res 1990; 58: 01-12
  • 20 Urano T, Sumiyoshi K, Nakamura M, Mori T, Takada Y, Takada A. Fluctuation of TPA and PAI-1 antigen levels in plasma: Difference of their fluctuation patterns between male and female. Thromb Haemostas 1990; 60: 133-139
  • 21 Vestal RE, Wood AJJ, Shand DG. Reduced β-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979; 26: 181-186
  • 22 Rydzewski A, Sakata K, Kobayashi A, Yamazaki N, Urano T, Takada Y, Takada A. Changes in plasminogen activator 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease. Haemostasis 1990; 20: 305-312
  • 23 Aranda A, Paramo JA, Rocha E. Fibrinolytic activity in plasma after gynecological and urological surgery. Haemostasis 1988; 18: 129-134
  • 24 Eriksson BI, Eriksson E, Risberg B. Impaired fibrinolysis and postoperative thromboembolism in orthopedic patients. Thromb Res 1991; 62: 55-64
  • 25 Sorensen JV, Lassen MR, Borris LC, Jorgensen PS, Schott P, Weber S, Murphy R, Walenga J. Postoperative deep vein thrombosis and plasma levels of tissue plasminogen activator inhibitor. Thromb Res 1990; 60: 247-251
  • 26 Sikorski JM, Hampson WG, Staddon GE. The natural history and aetiology of deep vein thrombosis after total hip replacement. J Bone Jt Surg (Br) 1981; 63-B: 171-177
  • 27 Planes A, Vochelle N, Fagola M. Total hip replacement and deep vein thrombosis. J Bone Jt Surg (Br) 1990; 72-B: 09-13
  • 28 Sharrock NE, Brien WW, Salvati EA, Mineo R, Garvin K, Sculco TP. The effect of intravenous fixed-dose heparin during total hip arthroplasty on the incidence of deep-vein thrombosis: A randomized, double-blind trial in patients operated on with epidural anesthesia and controlled hypotension. J Bone Jt Surg (Am) 1990; 72-A: 1456-1461
  • 29 Prins MH, Hirsh J. A comparison of general anesthesia and regional anesthesia as a risk factor for deep vein thrombosis following hip surgery: A critical review. Thromb Haemostas 1990; 64: 497-500
  • 30 Sharrock NE, Haas SB, Hargett MJ, Urquhart B, Insall JN, Scuderi G. Effects of epidural anesthesia on the incidence of deep-vein thrombosis after total knee arthroplasty. J Bone Jt Surg (Am) 1991; 73: 502-506
  • 31 Jorgensen LN, Rasmussen LS, Nielsen PT, Leffers A, Albrecht-Beste E. Antithrombotic efficacy of continuous extradural analgesia after knee replacement. Br J Anaesth 1991; 66: 08-12
  • 32 Davis GM, Laurenson VG, Gillespie WJ, Foate J, Seagar AD. Leg blood flow during total hip replacement under spinal or general anaesthesia. Anaesth Intens Care 1989; 17: 136-143
  • 33 Hamer JD, Malone PC, Silver IA. The PO2 in venous valve pockets: its possible bearing on thrombogenesis. Br J Surg. 1981; 68: 166-170
  • 34 Malone PC. A hypothesis concerning the aetiology of venous thrombosis. Med Hypotheses 1977; 3: 189-201
  • 35 Bowler GMR, Lamont MC, Scott DB. Effect of extradural bupivacaine or I. V diamorphine on calf blood flow in patients after surgery. Br J Anaesth 1987; 59: 1412-1419
  • 36 Freyschuss U, Hjemdahl P, Juhlin-Dannfelt A, Linde B. Cardiovascular and metabolic responses to low dose adrenaline infusion: an invasive study in humans. Clin Sci 1986; 70: 199-206
  • 37 Comerota A, Stewart G, Alburger P, Smalley K, White J. Operative venodilation: A previously unsuspected factor in the cause of postoperative deep vein thrombosis. Surgery 1989; 106: 301-309
  • 38 Nicolaides AN. Benefits of prophylaxis in general surgery. Acta Chir Scand Suppl 1990; 556: 25-29
  • 39 Takeuchi M, Nagura H, Kaneda T. DDAVP and epinephrine-induced changes in the localization of von Willebrand factor antigen in endothelial cells of human oral mucosa. Blood 1988; 72: 850-854
  • 40 Bazzoni G, Dejana E, Del Maschio A. Adrenergic modulation of human polymorphonuclear leukocyte activation. Potentiating effect of adenosine. Blood 1991; 77: 2042-2048
  • 41 Felez J. Biochemical aspects of the pathogenesis of venous thrombosis. Acta Chir Scand Suppl 1990; 556: 09-17